| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $65.3M | +87.0% |
| Cost of Revenue | $7.5M | +224.1% |
| R&D Expense | $91.6M | -1.8% |
| SG&A Expense | $60.9M | +11.7% |
| Operating Income | -$94.8M | +17.9% |
| Pre-tax Income | -$95.6M | -72.9% |
| Income Tax | $0 | — |
| Net Income | -$95.6M | -72.9% |
| EPS (Basic) | -$2.19 | -71.1% |
| EPS (Diluted) | -$2.19 | -71.1% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $105.8M | -41.7% |
| Accounts Receivable | $12.5M | +62.5% |
| Inventory | $6.7M | +21.6% |
| Current Assets | $130.4M | -35.5% |
| Total Assets | $141.5M | -33.5% |
| Current Liabilities | $28.3M | +1.5% |
| Total Liabilities | $32.2M | -1.4% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$75.9M | +26.0% |
| Capital Expenditures | $667K | +0.0% |
| Investing Cash Flow | $61.0M | +0.0% |
| Financing Cash Flow | $84K | -99.9% |
| Free Cash Flow | -$76.6M | +25.8% |
| Stockholders' Equity |
| $109.2M |
| -39.4% |